Article Text

Download PDFPDF
Global rising trends of atrial fibrillation: a major public health concern
  1. Nileshkumar J Patel1,
  2. Varunsiri Atti2,
  3. Raul D Mitrani1,
  4. Juan F Viles-Gonzalez3,
  5. Jeffrey J Goldberger1
  1. 1 Division of Cardiovascular Medicine, Department of Medicine, University of Miami-Miller School of Medicine, Jackson Memorial Hospital., Miami, Florida, USA
  2. 2 Department of Internal Medicine, Michigan State University-Sparrow Hospital, East Lansing, Michigan, USA
  3. 3 Department of Electrophysiology, Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, Louisiana, USA
  1. Correspondence to Dr Nileshkumar J Patel, Division of Cardiovascular Medicine, Department of Medicine, University of Miami-Miller School of Medicine, Jackson Memorial Hospital, Miami, FL 33136, USA; dr.nilesh.j.patel{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Atrial fibrillation (AF) is the most common arrhythmia worldwide and the estimated global age adjusted prevalence was 0.5% in 2010, representing nearly 33.5 million individuals.1 The prevalence is likely underestimated as a large proportion of asymptomatic individuals and those having transient symptoms remain undiagnosed. It is recognised as a global public health problem due to its significant burden of morbidity and mortality resulting from embolic stroke, congestive heart failure and acute coronary syndrome. AF may affect functional status and impairs the quality of life. The incremental cost related to AF in the USA is estimated at US$6–26 billion per year.2 Thus, AF already has tremendous implications on the economy and public health.

Numerous studies have reported AF as a growing epidemic with an expected doubling of its prevalence by 2030.3 However, most of the studies were conducted in the western world and epidemiological studies of AF in the Asian continent are scarce. Furthermore, the healthcare implications of the rapidly changing population dynamics in this region are poorly understood. As the prevalence is expected to rise, it is important to have an updated epidemiology of AF in order to allocate human and economic resources for appropriate healthcare planning. Two thirds of the AF-related healthcare expenses are from direct and indirect inpatient cost. Tremendous regional variation in hospitalisation for AF has been reported. Hence, the analysis of utilisation of hospitalisation is key to allocate resources accordingly.

In this context, Kim et al used the National Health Insurance Service (NHIS) database of Korea to describe the temporal trends of hospitalisation, costs, treatment …

View Full Text


  • Contributors Consent to submit has been received explicitly from all co-authors.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

  • Data sharing statement There are no data pertaining to this article.

Linked Articles